Press Releases
Lung Cancer
-
Jennerex Announces Data Presentations Relating to Oncolytic Virus JX-594 at American Society of Clinical Oncology Annual Meeting
Jennerex Announces Data Presentations Relating to Oncolytic Virus JX-594 at American Society of Clinical Oncology Annual Meeting PR Newswire SAN FRANCISCO, Calif. , May 16, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage...
-
Full Breadth and Depth of Accuray's Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31
Full Breadth and Depth of Accuray's Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31 PR Newswire SUNNYVALE, California , May 16, 2012 /PRNewswire/ -- Conference Presentations Highlighted Benefits of...
-
Lung Cancer Alliance Announces Important First Step Cleared For More Federal Funding For Lung Cancer Research
Lung Cancer Alliance Announces Important First Step Cleared For More Federal Funding For Lung Cancer Research PR Newswire Additional $10.5 million approved in FY2013 Department of Defense Lung Cancer Research Program for...
-
OgilvyEngage to Leverage Socially-Beneficial Behavior Change To Help Businesses Grow
OgilvyEngage to Leverage Socially-Beneficial Behavior Change To Help Businesses Grow New Practice to Offer Social Marketing Expertise to Corporate Clients PR Newswire NEW YORK , May 16, 2012 /PRNewswire/ -- Ogilvy...
-
Global Endometriosis Industry
Global Endometriosis Industry PR Newswire NEW YORK , May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Endometriosis Industry http://www.reportlinker.com/p0552779/Global-Endometriosis-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology...
-
Hot Stock Research for Pfizer, PepsiCo, Duke Energy, Regions Financial, Peabody Energy, and Renren
Hot Stock Research for Pfizer, PepsiCo, Duke Energy, Regions Financial, Peabody Energy, and Renren PR Newswire VANCOUVER, British Columbia , May 16, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading...
-
Syndax Pharmaceuticals Appoints Luke Evnin, Ph.D. to Board of Directors
Syndax Pharmaceuticals Appoints Luke Evnin, Ph.D. to Board of Directors PR Newswire WALTHAM, Mass. , May 16, 2012 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. , an oncology company moving into phase 3 having completed randomized,...
-
Rosetta Genomics Achieves Major Commercial Milestone by Obtaining Medicare Coverage of miRview mets2 Assay
Medicare Beneficiaries to Gain Access to Proprietary Test to Identify Tumor Origin in Cancer of Unknown and Uncertain Primary Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic...
-
48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012
48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012 -- First data from Phase III trial for regorafenib in gastrointestinal stromal tumor (GIST) presented...
-
Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting
Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting PR Newswire SOUTH SAN FRANCISCO, Calif. , May 16, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX)...
-
Global Human Vaccines Industry
Global Human Vaccines Industry PR Newswire NEW YORK , May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Human Vaccines Industry http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and...
-
Global Rechargeable Batteries Industry
Global Rechargeable Batteries Industry PR Newswire NEW YORK , May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Rechargeable Batteries Industry ...
-
In Vitro Diagnostics - A Global Market Overview
In Vitro Diagnostics - A Global Market Overview PR Newswire NEW YORK , May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: In Vitro Diagnostics - A Global Market...
-
Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2012 Financial Results
Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS) $2.2 million in revenue for second quarter 2012; $4.4 million in revenue for first half of fiscal year 2012 No-cost extension & modification of BARDA base year contract BARDA...
-
Helix BioPharma Corp. Commences Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that clinical site initiation and patient recruitment activities...
Follow us
What people say
Our Partners
© 2005-2012